A blood glucose level of 54 mg/dL or less was reported in 26% of patients receiving the 7 mg tablets, 30% of patients receiving the 14 mg tablets, and 32% with placebo
- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)
NICE advises that symptoms may start to improve within two weeks, but improvement can take up to three months
BPC-157 is a synthetic peptide derived from a natural molecule aptly named Body Protective Compound (i.e., BPC) that seems to protect and repair the gastrointestinal lining in animal studies